Risk assessment of over-the-counter cannabinoid-based cosmetics: Legal and regulatory issues governing the safety of cannabinoid-based cosmetics in the UAE
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.050.868 |
| Chemical and physical data | |
| Formula | C14H9Cl2N3O2 |
| Molar mass | 322.15 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
Lopirazepam (INN)[1] is a short-acting benzodiazepine analog of the pyridodiazepine type (specifically, the pyridodiazepine analog of lorazepam) with anxiolytic and hypnotic properties.[2][3] It has never been marketed.[4]
See also
References
- ^ US 4008223, von Bebenburg W, Offermanns H, "6-Aza-3H-1,4-benzodiazepines", issued 15 February 1977, assigned to Deutsche Gold und Silber Scheideanstalt and Evonik Operations GmbH.
- ^ Saletu M, Saletu B, Grünberger J, Mader R, Karobath M (1983). "Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients". Neuropsychobiology. 9 (2–3): 119–134. doi:10.1159/000117949. PMID 6353268.
- ^ Fabian A, Röhmel R, Kubicki S (September 1984). "[Changes in the length of sleep cycles during administration of flurazepam and lopirazepam]". EEG-EMG Zeitschrift für Elektroenzephalographie, Elektromyographie und Verwandte Gebiete (in German). 15 (3): 151–158. PMID 6435999.
- ^ Triggle DJ, Ganellin CR, MacDonald F (1996). Dictionary of Pharmacological Agents. Vol. 2. Boca Raton: Chapman & Hall/CRC. p. 1232. ISBN 0-412-46630-9. Retrieved on December 31, 2008 through Google Book Search.
